Aurobindo Pharma Limited: IPO, Share Price, Products, Financials & Investment Growth

admin_ash
3 Min Read

Aurobindo Pharma Limited: IPO, Share Price, Products, Financials & Investment Growth

Introduction to Aurobindo Pharma Limited

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company that produces generic pharmaceuticals and active pharmaceutical ingredients (APIs). Established in 1986, Aurobindo Pharma quickly gained a reputation for its high-quality products and affordable pricing, making it a significant player in the global pharmaceutical industry.

Aurobindo Pharma Limited IPO Details

The Initial Public Offering (IPO) of Aurobindo Pharma Limited was launched in 1995. The IPO was priced at ₹ 26 per share. This IPO marked a significant step in the company’s journey, providing them with the necessary capital to expand their operations and reach new markets.

Current Share Price of Aurobindo Pharma Limited

As of the most recent trading session, the current share price of Aurobindo Pharma Limited stands at ₹ XXX. The company has experienced substantial growth over the years, contributing to a steady rise in its stock price.

Product Range of Aurobindo Pharma Limited

Aurobindo Pharma Limited offers a wide array of products, including:

  • Antibiotics
  • Anti-Retrovirals
  • Cardiovascular products
  • Central Nervous System products
  • Gastroenterological products
  • Anti-Allergics
  • Vaccines

The company has a strong presence in over 150 countries, making it one of the largest pharmaceutical exporters from India.

Financial Performance of Aurobindo Pharma Limited

Aurobindo Pharma Limited has showcased impressive financial performance over the years. Here are some key financial metrics:

  • Revenue (FY 2022-23): ₹ XXX Crores
  • Profit After Tax (FY 2022-23): ₹ XXX Crores
  • Operating Margin: 20%
  • P/E Ratio: XX
  • Dividend Yield: X%

Investment Growth: Aurobindo Pharma Limited

Investing in Aurobindo Pharma Limited could have yielded significant returns. For instance, an investment of ₹10,000 in Aurobindo Pharma Limited 5 years ago would have grown substantially by now. Assuming an average annual growth rate of XX%, the current value of this investment would be approximately ₹ YYY.

Such impressive growth makes Aurobindo Pharma Limited an attractive option for both short-term and long-term investors.

In conclusion, Aurobindo Pharma Limited stands as a robust and reliable entity in the pharmaceutical industry. With its consistent financial performance, a diverse range of products, and a growing global presence, the company offers promising investment opportunities.

Share this Article
Leave a comment